Central nervous system neoplasm – Diagnostics – Overview of Information and Clinical Research

Finding out what’s happening inside your body when you have symptoms can feel overwhelming, but modern medicine offers many tools to identify central nervous system tumors. Understanding what tests might be needed and why they’re important can help you feel more prepared and less anxious about the process ahead.

Introduction: Who Should Seek Diagnostic Testing

If you experience certain warning signs affecting your brain or spinal cord, it’s important to see a doctor who can determine whether diagnostic testing is needed. Central nervous system tumors can cause a variety of symptoms that depend on where the tumor is located and how large it has grown. Not everyone with these symptoms has a tumor, but they should never be ignored.^[1]

People who should consider seeking medical evaluation include those experiencing persistent headaches, especially morning headaches that improve after vomiting. Seizures that occur for the first time in adulthood are another significant warning sign. Changes in vision, hearing, or speech that develop gradually or suddenly can indicate pressure on specific brain areas. Loss of appetite combined with frequent nausea and vomiting may suggest increased pressure inside the skull. Additionally, noticeable changes in personality, mood, ability to focus, or behavior patterns warrant medical attention.^[1]^[7]

The symptoms aren’t the same for everyone because they depend on which part of your central nervous system is affected. Some parts of the brain control movement, others control speech or memory, and still others manage balance and coordination. When a tumor grows in a less active area of the brain, it might not cause noticeable symptoms until it becomes quite large. This is why some tumors are found only after they’ve grown substantially.^[4]

Individuals with certain inherited conditions face higher risk and may need more vigilant monitoring. Those with neurofibromatosis (a genetic disorder that causes tumors to form on nerve tissue), von Hippel-Lindau disease, or tuberous sclerosis should discuss screening recommendations with their healthcare providers, as these conditions increase the likelihood of developing central nervous system tumors.^[8]^[10]

⚠️ Important

Both cancerous and non-cancerous tumors in the brain or spinal cord can cause serious symptoms and require treatment. Even tumors that don’t contain cancer cells can press on surrounding brain tissue and interfere with normal function. The term “benign” doesn’t mean a tumor is harmless—it simply means it doesn’t spread to other parts of the body like cancer does.^[1]

Classic Diagnostic Methods

When your doctor suspects a central nervous system tumor, several types of examinations and tests help confirm the diagnosis and determine the exact nature of the problem. The diagnostic process typically begins with simpler evaluations and progresses to more detailed imaging studies.

Neurological Examination

The first step in diagnosis is usually a thorough neurological exam, which tests how well different parts of your brain and nervous system are working. During this exam, your doctor checks your vision, hearing, balance, coordination, muscle strength, and reflexes (automatic responses your body makes to certain stimuli, like your knee jerking when tapped). The doctor may also test your ability to feel sensations like touch, temperature, and pain in different parts of your body.^[8]^[16]

A neurological exam doesn’t directly detect a tumor, but it provides important clues about which part of your brain might be affected. If you have trouble with one or more areas—for example, weakness on one side of your body or difficulty with balance—this helps the doctor understand where a problem might exist and what tests should come next.^[16]

CT Scans

A CT scan (computed tomography) uses X-rays to create detailed pictures of the inside of your head. This test is widely available and produces results quickly, which is why it’s often the first imaging test performed if you have headaches or other symptoms that could have many possible causes. The CT scan can detect problems in and around your brain, giving your healthcare team clues about what might be happening.^[16]

During a CT scan, you lie on a table that slides into a large, doughnut-shaped machine. The machine rotates around you, taking multiple X-ray images from different angles. A computer then combines these images to create cross-sectional views of your brain. Sometimes a contrast dye is injected into your vein before the scan to make certain structures show up more clearly on the images.^[16]

MRI Scans

An MRI (magnetic resonance imaging) scan is considered the most important imaging test for detecting brain tumors because it shows brain tissue more clearly than other tests. MRI uses powerful magnets and radio waves instead of X-rays to create detailed pictures of the inside of your body. This test is particularly good at showing the difference between a tumor and healthy brain tissue.^[16]

The MRI procedure takes longer than a CT scan, often 30 to 60 minutes, and you must remain very still inside a narrow tube while the machine works. Many people find the enclosed space uncomfortable, and the machine makes loud knocking and buzzing sounds. If you feel anxious about enclosed spaces, your doctor can provide medication to help you relax during the test.^[16]

A dye called contrast material is usually injected into your arm vein before an MRI. This dye helps make certain details more visible and makes it easier to see smaller tumors. It also helps doctors distinguish between tumor tissue and swelling or inflammation in the surrounding brain. Some patients may need special types of MRI that provide additional information about blood flow in the tumor or the chemical makeup of the tissue.^[16]

Biopsy Procedures

After imaging tests suggest the presence of a tumor, a biopsy is usually necessary to make a definitive diagnosis. A biopsy involves removing a small sample of tissue so it can be examined under a microscope by a specialist called a pathologist. This examination reveals whether the tumor is cancerous or non-cancerous and identifies the specific type of tumor you have.^[1]

Sometimes the biopsy happens as part of surgery to remove the tumor. In other cases, a surgeon performs a separate biopsy procedure before deciding on the best treatment approach. The tissue sample helps doctors understand how aggressive the tumor is and what treatments are most likely to work. Increasingly, doctors also examine the tumor tissue for genetic and molecular features that can guide treatment decisions more precisely.^[9]

There are situations where a biopsy cannot be safely performed. Some tumors are located in areas of the brain that are too difficult or dangerous to reach without causing serious harm. In these cases, doctors make treatment decisions based on imaging characteristics and clinical symptoms alone.^[1]

Additional Specialized Tests

Depending on what initial tests reveal, your doctor may recommend additional diagnostic procedures. A lumbar puncture, also called a spinal tap, involves inserting a thin needle into your lower back to collect a small amount of cerebrospinal fluid (the clear liquid that surrounds your brain and spinal cord). This test can detect whether tumor cells have spread into the fluid around your brain and spinal cord.^[8]

For tumors in or near the spine, similar imaging tests are used, but they focus on the spinal column and surrounding structures. Spinal tumors may require specialized MRI sequences to fully visualize the extent of the tumor and its relationship to the spinal cord and nerve roots.^[1]

Diagnostic Testing for Clinical Trial Qualification

Clinical trials test new treatments or new combinations of existing treatments to find better ways to help people with central nervous system tumors. If you’re considering participating in a clinical trial, you’ll need to undergo specific tests to determine whether you’re eligible to join the study. These requirements exist to ensure that researchers can accurately measure how well the treatment works and to protect patient safety.

Tissue Classification Requirements

Most clinical trials for central nervous system tumors require that your tumor be classified according to the World Health Organization (WHO) classification system. This system categorizes tumors based on how they look under the microscope and, increasingly, on their genetic and molecular characteristics. The classification helps predict how the tumor is likely to behave and which treatments might work best.^[9]

The WHO system assigns tumors a grade from I to IV. Grade I tumors grow slowly and are the least aggressive, while Grade IV tumors grow quickly and are the most aggressive. Understanding your tumor’s grade is essential because many clinical trials only accept patients with specific tumor grades. For example, a trial testing a new treatment for aggressive tumors might only accept patients with Grade III or Grade IV tumors.^[9]

Modern tumor classification now includes genetic testing of the tumor tissue. Scientists have discovered that certain genetic changes in tumor cells affect how tumors respond to treatment. Some clinical trials specifically look for patients whose tumors have particular genetic features. Your doctors may test your tumor for genetic markers such as IDH mutations, MGMT methylation status, or other molecular characteristics that influence treatment selection.^[9]

Imaging Studies for Trial Entry

Before joining a clinical trial, you’ll typically need baseline imaging studies—usually an MRI scan with contrast dye. These images establish the size and location of your tumor before treatment begins. Throughout the trial, you’ll have repeat MRI scans at specified intervals so researchers can measure whether the tumor is shrinking, staying the same size, or growing. These measurements help determine whether the treatment being tested is effective.^[8]

Clinical trials have strict rules about how soon before enrollment you must have an MRI and what type of MRI sequences must be used. This standardization ensures that all patients in the study are evaluated the same way, making the results more reliable and meaningful.

Functional Status Assessment

Researchers need to know how well you can perform daily activities before you start a clinical trial. They use standardized scoring systems to measure your functional status—your ability to care for yourself, work, and engage in normal activities. These scores help determine whether you’re healthy enough to tolerate the treatment being tested and allow researchers to track how treatment affects your quality of life.^[8]

The most commonly used system is called the Karnofsky Performance Status or the ECOG Performance Status. These scales range from normal activity with no limitations to being completely disabled and requiring full care. Most clinical trials require that you have a minimum performance status score to participate, ensuring you’re strong enough to safely receive the experimental treatment.

⚠️ Important

Meeting the eligibility criteria for a clinical trial doesn’t guarantee you’ll benefit from the experimental treatment. Clinical trials test whether new approaches work better than standard treatments, but some patients receive standard care as part of the comparison group. Your doctors will explain all aspects of trial participation, including potential risks and benefits, before you decide whether to join.

Laboratory Testing Requirements

Before joining a clinical trial, you’ll need various blood tests to ensure your organs are functioning well enough to handle the experimental treatment. These typically include tests of your liver function, kidney function, and blood cell counts. Some treatments can affect these organs, so researchers need to know your baseline values and monitor you carefully throughout the study.^[8]

Depending on the specific trial, you might need additional specialized tests. For example, if the experimental treatment could affect your heart, you might need an electrocardiogram (a test that records your heart’s electrical activity) or an echocardiogram (an ultrasound of your heart) before enrolling.

Neurological Function Testing

Many clinical trials include detailed assessments of your neurological function beyond the standard neurological exam. These might include formal cognitive testing to measure memory, attention, and thinking skills, or questionnaires about symptoms like pain, fatigue, or emotional wellbeing. These assessments help researchers understand not just whether the tumor changes in size, but whether the treatment improves or preserves your ability to think clearly and maintain quality of life.

The specific diagnostic requirements vary greatly depending on which clinical trial you’re considering. Each trial has a detailed protocol that spells out exactly what tests are needed and when. Your healthcare team can explain which tests you’ll need for any trial you’re considering and help you understand what to expect throughout the process.

Prognosis and Survival Rate

Prognosis

The outlook for patients with central nervous system tumors depends on many factors that work together to influence how the disease progresses. One of the most important factors is the type and grade of the tumor. Lower-grade tumors (Grade I and II) generally grow more slowly and have better outcomes than higher-grade tumors (Grade III and IV). The specific cell type—such as whether it’s an astrocytoma, oligodendroglioma, meningioma, or another variety—also significantly affects prognosis.^[1]

The tumor’s location in the brain or spinal cord matters tremendously because some areas are more critical than others and more difficult to treat without causing damage to surrounding tissue. A tumor in an area that controls vital functions like breathing or heart rate poses greater challenges than one in a less critical location. Similarly, the size of the tumor and whether it can be completely removed with surgery influences outcomes.^[1]

Patient-related factors also play an important role in prognosis. Younger patients generally have better outcomes than older adults. Your overall health status and how well you can perform daily activities before treatment—measured by performance status scores—affects both your ability to tolerate treatment and your ultimate outcome. Certain genetic changes in the tumor cells can make tumors more or less aggressive and more or less responsive to treatment, which is why molecular testing has become increasingly important.^[8]^[9]

For the most aggressive primary brain tumor, glioblastoma multiforme, older adults with this disease rarely live longer than one year despite treatment. However, for some childhood tumors like medulloblastoma, improved treatment approaches have resulted in longer survival with better quality of life. The outcomes vary enormously depending on all these factors working together.^[3]

Survival Rate

Data from the United States shows that the combined incidence of brain and other central nervous system tumors was 6.2 cases per 100,000 people per year for the period 2017 to 2021. The mortality rate was 4.4 deaths per 100,000 people per year based on deaths from 2018 to 2022. In 2025, an estimated 24,820 new cases of brain and nervous system tumors will be diagnosed in the United States, with approximately 18,330 deaths expected.^[8]^[10]

These overall statistics combine many different types of central nervous system tumors with vastly different outcomes. Some benign tumors like certain meningiomas can often be completely removed with surgery and may not recur, leading to excellent long-term survival. At the other end of the spectrum, glioblastoma has much lower survival rates despite aggressive treatment.^[3]

It’s important to understand that statistics represent averages across large groups of patients and cannot predict what will happen to any individual person. Many factors unique to you—including your specific tumor type, its location and size, your age and overall health, the treatments you receive, and how your tumor responds to those treatments—all influence your personal outcome. Your healthcare team can provide more specific information about prognosis based on your individual circumstances.^[1]

#1 Clinical Trials Search in Europe